Immune Thrombocytopenic Purpura in Patients with COVID-19 | Zendy

Sabine Revuz | Zendy; N. Vernier | Zendy; Leilah Saadi | Zendy; J. Campagne | Zendy; Sophie Poussing | Zendy; F. Maurier | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Immune Thrombocytopenic Purpura in Patients with COVID-19

Author(s) -

Sabine Revuz,

N. Vernier,

Leilah Saadi,

J. Campagne,

Sophie Poussing,

F. Maurier

Publication year - 2020

Publication title -

european journal of case reports in internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.125

H-Index - 1

ISSN - 2284-2594

DOI - 10.12890/2020_001751

Subject(s) - medicine , intravenous immunoglobulins , mucocutaneous zone , covid-19 , immune system , thrombocytopenic purpura , antibody , immunology , purpura (gastropod) , immune thrombocytopenia , mechanism (biology) , disease , virology , infectious disease (medical specialty) , outbreak , ecology , biology , philosophy , epistemology

We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were successfully treated with intravenous immunoglobulins without later relapse.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research